These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20451610)

  • 1. Transglutaminase 2 protects against ischemic stroke.
    Filiano AJ; Tucholski J; Dolan PJ; Colak G; Johnson GV
    Neurobiol Dis; 2010 Sep; 39(3):334-43. PubMed ID: 20451610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
    Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
    FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
    Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
    Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G; Johnson GV
    Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
    Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
    Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
    Quinn BR; Yunes-Medina L; Johnson GVW
    J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
    Kumar S; Donti TR; Agnihotri N; Mehta K
    Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.
    Yunes-Medina L; Feola J; Johnson GVW
    Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
    Colak G; Keillor JW; Johnson GV
    PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
    Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transglutaminase 2 in A
    Vyas FS; Nelson CP; Dickenson JM
    Eur J Pharmacol; 2018 Jan; 819():144-160. PubMed ID: 29208472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
    Gundemir S; Johnson GV
    PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.
    Cho SY; Jeong EM; Lee JH; Kim HJ; Lim J; Kim CW; Shin DM; Jeon JH; Choi K; Kim IG
    Mol Cells; 2012 Mar; 33(3):235-41. PubMed ID: 22382681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
    Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
    Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Dependent Expression of TG2 Isoforms in Neuroblastoma Cells as Consequence of Different MYCN Amplification Status.
    Currò M; Ferlazzo N; Giunta ML; Montalto AS; Russo T; Arena S; Impellizzeri P; Caccamo D; Romeo C; Ientile R
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
    Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.
    Shweke N; Boulos N; Jouanneau C; Vandermeersch S; Melino G; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
    Am J Pathol; 2008 Sep; 173(3):631-42. PubMed ID: 18688035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.